Nicotinic antagonist
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Please Join in Editing This Page and Apply to be an Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [2] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.
Overview
A nicotinic antagonist is a type of anticholinergic which inhibits the action at nicotinic acetylcholine receptors. These compounds are mainly used for peripheral muscle paralysis in surgery, but some centrally acting compounds such as mecamylamine and 18-methoxycoronaridine block nicotinic acetylcholine receptors in the brain and can be used for treating drug addiction.
| Mechanism | Antagonist | Preferred receptor | Clinical use |
|---|---|---|---|
| Ganglionic blocking agents | Hexamethonium | Ganglion type | none[1] |
| Mecamylamine | Ganglion type | ||
| Trimethaphan | Ganglion type | Rarely used for blood pressure decrease during surgery[1] | |
| Nondepolarizing neuromuscular blocking agents | Atracurium | Muscle type | muscle relaxant in anaesthesia[1] |
| Doxacurium | Muscle type | ||
| Mivacurium | Muscle type | ||
| Pancuronium | Muscle type | muscle relaxant in anaesthesia[1] | |
| Tubocurarine | Muscle type | Rarely used [1] | |
| Vecuronium | Muscle type | muscle relaxant in anaesthesia[1] | |
| Depolarizing neuromuscular blocking agents | Succinylcholine | Muscle type | |
| Centrally acting nicotinic antagonists | 18-Methoxycoronaridine | α3β4 |
References
External links
- Nicotinic+antagonists at the US National Library of Medicine Medical Subject Headings (MeSH)